You can narrow down the results using the filters
-
Once-daily oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis. The Einstein-DVT dose-finding study.
Expand description -
SAFETY AND EFFICACY OF AMBISOME VS CONVENTIONAL AMPHOTERICIN B IN THE TREATMENT OF PATIENTS WITH SUSPECTED OR CONFIRMED MYCOSIS
Expand description -
A pilot study of psychotherapeutic intervention for complex presentations of first-episode psychosis
Expand description -
Cardiovascular and Periodontal Study: a randomised controlled trial
Expand description -
A PHARMACOKINETIC PHASE I STUDY TO ASSESS THE COMPARATIVE BIOAVAILABILITY OF 17-B-ESTRADIOL FROM A METERED DOSE TRANSDERMAL SYSTEM (MDTS) AND ESTRADERM 50 PATCHES IN HEALTHY POSTMENOPAUSAL WOMEN, AS HORMONE REPLACEMENT THERAPY
Expand description -
Phase III trial of an immunotherapy for Stage III (AJCC) melanoma based on cultured autologous dendritic cells presenting autologous tumour cell antigens
Expand description -
Prostate Cancer: An internal, solid-malignancy model for vaccine therapy
Expand description -
Neoadjuvant chemotherapy with docetaxel and anthracycline based chemotherapy in patients with advanced breast cancer: Evaluation of biological, clinical and imaging markers of tumour response.
Expand descriptionThis study is evaluating the effect of neoadjuvant chemotherapy with docetaxel and anthracycline in patients with advanced breast cancer. Who is it for? You may be eligible to join this study if you are a female aged 18 years or above who has a diagnosis of locally advanced breast cancer. Study details Participants in this study will be randomly (by chance) allocated to one of two groups. Participants in one group will undergo 4 cycles of chemotherapy with docetaxel followed by 4 cycles of chemotherapy with anthracycline. Participants in the other group will receive the same treatments in reverse order. The overall duration of treatment in each group is 24 weeks. All participants will be monitored for up to 5 years in order to evaluate clinical response and to identify markers that correlate with tumour response to chemotherapy. Assessments required include clinical examinations, mammogram, PET scan, MRI scan, blood tests and biopsy. We believe this study may help us in individualising cancer treatment.
-
An Antireflux Anastomosis Following Oesophagectomy
Expand description -
A Randomised Trial Of Barretts Ablation: YAG Laser vs Argon Plasma Coagulation
Expand description